These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Blood and its derivatives in the treatment of hypoprotoinemia in children]. Prusek W Wiad Lek; 1968 Jun; 21(11):951-5. PubMed ID: 5669417 [No Abstract] [Full Text] [Related]
24. Optimal use of blood components and derivatives. Walter WJ; Oberman HA Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570 [No Abstract] [Full Text] [Related]
25. [The use of plasma substitutes and albumin in blood component therapy]. Lundsgaard-Hansen P; Tschirren B Klin Anasthesiol Intensivther; 1980; 21():120-35. PubMed ID: 7453077 [No Abstract] [Full Text] [Related]
26. Modern transfusion practice. Jeffrey HC Health Bull (Edinb); 1976 May; 34(3):125-40. PubMed ID: 950294 [No Abstract] [Full Text] [Related]
27. [Effect of transfusion of albumin, plasma and stored blood on serum proteins in malnourished infants]. Prusek W Pol Tyg Lek; 1968 Sep; 23(34):1268-72. PubMed ID: 5725346 [No Abstract] [Full Text] [Related]
28. [Value of human blood fractionation to better clinical efficiency of blood transfusion therapy]. Rodríguez Moyado H; Uribe Cortes JA Sangre (Barc); 1973; 18(4):155-60. PubMed ID: 4792896 [No Abstract] [Full Text] [Related]
29. [Good use of blood transfusions: principal indications for hemotherapy]. Goudemand M; Bauters F; Parquet-Gernez A Lille Med; 1974; 19 Spec No():377-85. PubMed ID: 4437301 [No Abstract] [Full Text] [Related]
30. Modern principles of blood transfusion therapy. Wallas CH; Panlilio AL; Jenkins DE J Tenn Med Assoc; 1978 Sep; 71(9):651-8. PubMed ID: 703308 [No Abstract] [Full Text] [Related]
32. The development of plasma derivatives in Australia. Schiff P Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156 [No Abstract] [Full Text] [Related]
33. [New aspects of therapy with blood and blood components]. Frick U; Frick G Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422 [TBL] [Abstract][Full Text] [Related]
34. What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors? Vox Sang; 1983; 44(4):246-59. PubMed ID: 6845681 [No Abstract] [Full Text] [Related]
38. [Blood component therapy--a transfusion plan for consequent use in volume replacement, in mass transfusion and in shock]. Glück D; Kubanek B; Ahnefeld FW Anaesthesiol Reanim; 1987; 12(3):131-44. PubMed ID: 3620067 [No Abstract] [Full Text] [Related]
39. [Basic problems with current blood transfusion technics]. Ostrowska W Pieleg Polozna; 1979; (5):16-7, 22. PubMed ID: 257666 [No Abstract] [Full Text] [Related]